Resistance to Ibritumomab in Lymphoma
Redigert av Jean-Francois Chatal, Makoto Hosono, 2019.Del av serien Resistance to Targeted Anti-Cancer Therapeutics.
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 20 dager
Oppdag mer
Resistance to Ibritumomab in Lymphoma
Redigert av Jean-Francois Chatal, Makoto Hosono, 2019.Del av serien Resistance to Targeted Anti-Cancer Therapeutics.
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
Oppdag mer
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 20 dager
Ved å fullføre kjøpet aksepterer du kjøpsvilkårene.
